Condition

Adenocarcinoma (1)

Heregulin (1)

NSCLC (1)

Non-Small Cell Lung Cancer (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Elevation Oncology (1)

Collaborator

Merrimack Pharmaceuticals (1)

Intervention

docetaxel (1)

mm-121 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

heregulin

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC, NSCLC, Adenocarcinoma Trial in Worldwide (MM-121, Docetaxel)

Terminated

Non-Small Cell Lung Cancer
+3 more

Tucson, Arizona
+34 more

Oct 11, 2021